KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Conference item |
Publicado: |
2012
|
Sumario: |
---|